Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells.
Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells.
复制标题
增强的外排活性促进休眠细菌细胞的药物耐受性
DOI:
10.1016/j.molcel.2016.03.035
复制
发表时间:
2016-04-21
期刊:
影响因子:
16
通讯作者:
Bai F
中科院分区:
文献类型:
--
作者:
Pu Y;Zhao Z;Li Y;Zou J;Ma Q;Zhao Y;Ke Y;Zhu Y;Chen H;Baker MAB;Ge H;Sun Y;Xie XS;Bai F
Natural variations in gene expression provide a mechanism for multiple phenotypes to arise in an isogenic bacterial population. In particular, a sub-group termed persisters show high tolerance to antibiotics. Previously, their formation has been attributed to cell dormancy. Here we demonstrate that bacterial persisters, under β-lactam antibiotic treatment, show less cytoplasmic drug accumulation as a result of enhanced efflux activity. Consistently, a number of multi-drug efflux genes, particularly the central component TolC, show higher expression in persisters. Time-lapse imaging and mutagenesis studies further establish a positive correlation between tolC expression and bacterial persistence. The key role of efflux systems, among multiple biological pathways involved in persister formation, indicates that persisters implement a positive defense against antibiotics prior to a passive defense via dormancy. Finally, efflux inhibitors and antibiotics together effectively attenuate persister formation, suggesting a combination strategy to target drug tolerance. Persisters accumulate fewer antibiotics as a direct result of increased efflux rate Persisters show higher expression of efflux-associated genes High expression of tolC is critical to promote persister formation Persisters combine active efflux and passive dormancy to survive antibiotic attack By using in vivo fluorescent imaging and next-generation sequencing, Pu et al. demonstrate that bacterial persisters exhibit enhanced efflux activity in addition to physiological quiescence, a double insurance strategy to ensure its survival under antibiotic attack.